Life Sciences, Business Risk, Marketing
Few would argue that life sciences is not a risky industry. But a firm’s risk depends in part on the stage of its offerings in traditional product life cycles. A new Ernst and Young report that assesses the nature of risk in the life sciences industry contains instructive information for ad agencies who help drug companies market their products.




FOLLOW US